1DQ8 | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG AND COA |
1DQ9 | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG-COA |
1DQA | A:587-703; C:587-703; D:587-703; B:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG, COA, AND NADP+ |
1HW8 | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH COMPACTIN (ALSO KNOWN AS MEVASTATIN) |
1HW9 | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH SIMVASTATIN |
1HWI | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATIN |
1HWJ | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH CERIVASTATIN |
1HWK | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN |
1HWL | A:587-703; B:587-703; C:587-703; D:587-703 | COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ROSUVASTATIN (FORMALLY KNOWN AS ZD4522) |
2Q1L | A:587-703; B:587-703; C:587-703; D:587-703 | DESIGN AND SYNTHESIS OF PYRROLE-BASED, HEPATOSELECTIVE HMG-COA REDUCTASE INHIBITORS |
2Q6B | A:587-703; B:587-703; C:587-703; D:587-703 | DESIGN AND SYNTHESIS OF NOVEL, CONFORMATIONALLY RESTRICTED HMG-COA REDUCTASE INHIBITORS |
2Q6C | A:587-703; B:587-703; C:587-703; D:587-703 | DESIGN AND SYNTHESIS OF NOVEL, CONFORMATIONALLY RESTRICTED HMG-COA REDUCTASE INHIBITORS |
2R4F | A:587-703; B:587-703; C:587-703; D:587-703 | SUBSTITUTED PYRAZOLES AS HEPATSELECTIVE HMG-COA REDUCTASE INHIBITORS |
3BGL | A:587-703; B:587-703; C:587-703; D:587-703 | HEPATOSELECTIVITY OF STATINS: DESIGN AND SYNTHESIS OF 4-SULFAMOYL PYRROLES AS HMG-COA REDUCTASE INHIBITORS |
3CCT | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CCW | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CCZ | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CD0 | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CD5 | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CD7 | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CDA | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |
3CDB | A:587-703; B:587-703; C:587-703; D:587-703 | THERMODYNAMIC AND STRUCTURE GUIDED DESIGN OF STATIN HMG-COA REDUCTASE INHIBITORS |